Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Camila Braganca Xavier

Assistant Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

Articles (12)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Ana Carolina Veneziani

Assistant Professor

University of Toronto

CANADA

View details

Aung Naing

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Apostolia M. Tsimberidou

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Anil Korkut

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Allan Pereira

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES

View details

Lipika Goyal

Director of Gastrointestinal Oncology

Stanford University

UNITED STATES

View details

J. Bryan Iorgulescu

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

David S. Hong

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Carlos Torrado

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Camila Braganca Xavier

Research Interests

Make your next move.

Explore related searches

Articles (12)

Personalized Therapy in Advanced Cholangiocarcinoma: Contemporary Treatment Approaches and Future Directions

Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications

Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid Tumors

Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit

Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial

Identifying predictors of overall survival among patients with TMB-low metastatic cancer treated with immune checkpoint inhibitors

A Comprehensive Exploration of Agents Targeting Tumor Microenvironment: Challenges and Future Perspectives

Cardiovascular and Thromboembolic Events in Patients With Localized Prostate Cancer Receiving Intensified Neoadjuvant Androgen Deprivation: A Systematic Review and Meta-Analysis

Primary Peritoneal Carcinosarcoma in a Breast Cancer Patient Harboring a Germline BRCA Pathogenic Variant: Case Report

Survival and Response Outcomes for Gastrointestinal Neuroendocrine Tumor (GEP-NETs) Patients Treated with Lutetium—177-DOTATATE in a Brazilian Reference Center: A Six-Year Follow-Up Experience

Suspected Germline TP53 Variants and Clonal Hematopoiesis of Indeterminate Potential: Lessons Learned From a Molecular Tumor Board

Complete Response to Sequential Human Epidermal Growth Factor Receptor 2–Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2–Amplified Metastatic Bladder Cancer

Collaborators (9)

Ana Carolina Veneziani

Aung Naing

Apostolia M. Tsimberidou

Anil Korkut

Allan Pereira

Lipika Goyal

J. Bryan Iorgulescu

David S. Hong

Carlos Torrado

Make your next move.